Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03833167
Brief Title: Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

First Submitted : February 4, 2019
First Submitted that Met QC Criteria : February 4, 2019
First Posted : February 6, 2019

Last Update Submitted that Met QC Criteria : September 15, 2021
Last Update Posted : September 16, 2021 (Estimate)